Age-at-onset (AAO) of schizophrenia appears to be influenced by various factors including gender and genetics. Males appear to be affected earlier than females and variants of brain-derived neurotrophic factor (BDNF) and of dopamine receptor D3 (DRD3) genes, which are thought to be functionally related, 1 may affect AAO of schizophrenia. 2 However, no study has evaluated multiple single-nucleotide polymorphisms (SNPs) covering these two genes and their effect on AAO of schizophrenia.
We report here analyses of 10 and 5 polymorphisms spanning DRD3 and BDNF genes, respectively. Two hundred thirty-eight Caucasian patients (163 men, 75 women) who were diagnosed with schizophrenia before age 40 were included. They were recruited from three clinical sites in North America: the Centre for Addiction and Mental Health in Toronto (Drs GR and JLK, n = 112); Case Western Reserve University in Cleveland, Ohio (Dr HYM, n = 72); Hillside Hospital in Glen Oaks, New York (Dr JAL, n = 54). All four clinicians are highly experienced in schizophrenia assessment. Subjects were recruited based on their diagnoses of schizophrenia according to DSM-III-R or DSM-IV and the availability of AAO data. The AAO was defined as the age when the subject first met DSM criteria for schizophrenia. All SNPs were genotyped using standard ABI TaqMan assay protocols. Genotypes were assigned manually post-amplification on the ABI 7500 Sequence Detection System. No significant differences in genotype and sex distributions between the samples from the three different clinical sites were noted using w 2 tests with SPSS software, allowing the samples to be pooled. Hardy-Weinberg equilibrium was respected for the SNPs reported here. The influence of AAO of schizophrenia was studied by two complementary analyses: analysis of variance was performed for mean AAOs, and survival analysis (Cox proportional hazards model) was used to estimate the effect of gender and genotype on AAO of schizophrenia using SPSS (version 14.0.2). Results for the Cox model were corrected for multiple testing using SNP Spectral Decomposition and SNPSpD software, which take into account the linkage disequilibrium between the markers and, the Meff Li correction, which gives the effective number of independent polymorphisms. 3, 4 Mean AAO of schizophrenia was 19.275 and 21.376 years, in males and females, respectively (P = 0.005). Using mean AAO analysis, significant associations were obtained for several SNPs of the DRD3 gene (Table 1) . These results were significant only in males and were not corrected for multiple testing. However, the same SNPs were significantly associated with AAO, even after correction, using the Cox model with sex as a covariable (Figure 1a ). The significant SNPs were located in the 5 0 half of the DRD3 gene and included the functional Ser9Gly polymorphism. 5 Since the Hapmap data in Caucasian population identified only three blocks in DRD3 gene with our 10 SNPs covering the entire gene length, we have reasonable coverage of the gene. An allele-dose effect was noted (Figure 1b ). Although this is the first analysis of several SNPs covering the DRD3 gene in relation to AAO of schizophrenia, our results obtained with the Ser9Gly are in agreement with two previous studies reporting an earlier AAO for the carriers of the Gly allele, notably in males 6, 7 (but, see also Gourion and Ohara et al. 2, 8 ). A clear demonstration of the functionality of the Ser9Gly polymorphism has been reported recently. 5 Interestingly, and in agreement with the role of dopamine in the etiopathology of schizophrenia, the carriers of the Gly allele may have enhanced affinity for endogenous dopamine and thus be more responsive to its effects. 5 By this mechanism, the Gly allele could lead to an earlier AAO. On the other hand, the SNPs located in the 5 0 region of the DRD3 gene that were significant may be associated because of the presence of linkage disequilibrium with the Ser9Gly polymorphism or because of a more direct effect on DRD3 promoter function.
Since the expression of the DRD3 is controlled by BDNF, 1 we also explored several SNPs covering the BDNF gene. The analysis of HapMap data for Caucasian showed one large haplotype block for BDNF gene; therefore with the five SNPs typed in this sample, we get a reasonable coverage of the gene. None of the SNPs studied were significantly associated with AAO using the Cox model (all P > 0.18) or the mean AAO analysis (Table 1) . It has been suggested recently that the Met allele may facilitate an earlier AAO of the disease; 2,9 however, we did not replicate these findings in our sample. Further studies evaluating several SNPs covering the BDNF gene are needed to validate our findings. The expected power for the AAO considering three genotype groups and a sample size of 238 subjects is 93-26% for an effect size ranging from 0.25 to 0.10 (http://www.psycho.uni-duesseldorf.de/aap/projects/gpower/). Therefore, our power was reasonable; however, it is likely that we did not have sufficient statistical power to detect effect sizes at the lower end of this range.
These results suggest that polymorphisms of the DRD3 gene, but not the BDNF gene, are modulating the AAO of schizophrenia. The effects are noted mostly in males and appear to be associated with several markers of the 5 0 region of the DRD3 gene. These findings may reflect an enhanced response to dopamine provided by the Ser9Gly polymorphism. 5 It has long been suspected that the DRD3 gene might be involved in the risk of schizophrenia. Although the latest meta-analysis conducted in over 11 000 subjects did not confirm these initial findings, 10 this could be due to high heterogeneity in such a large sample. Overall, our results suggest that the DRD3 gene may influence the AAO of schizophrenia. Cocaine use affects more than 30 million people in this country, and is responsible for the majority of deaths ascribed to drug overdose. 1 While the pharmacodynamics of cocaine toxicity are increasingly understood, the molecular determinants that define fatal outcome remain largely unknown. Indeed, in cocaine poisoning the mainstay of management is supportive, limited predominantly to sedation and monitoring of vital signs. 2 Here, we report that the susceptibility to cocaine-induced mortality is genetically controlled. By identifying the KCNJ11 gene as a safeguard element in the response to cocaine overdose, the present study unmasks a previously unrecognized framework for targeted therapy of cocaine intoxication.
An overdriven activation of the sympathetic nervous system, which results in a mismatch of demand and supply producing seizures, heart rhythm disorders and cardiopulmonary collapse, is an established substrate of cocaine toxicity. 3 By inhibiting reuptake of catecholamines in presynaptic neurons, cocaine induces an excessive accumulation of sympathetic neurotransmitters, resulting in a general state of hyperadrenergic stimulation. 4 Distributed throughout the body, ATP-sensitive K þ (K ATP ) channels have been recently implicated in securing tolerance to systemic stress imposed by a sympathetic surge. 5 K ATP channels operate as unique molecular rheostats, capable of adjusting membrane potential-dependent functions to match cellular metabolic demands. 6 Underscoring the critical role for K ATP channels in vital homeostatic functions, targeted disruption of KCNJ11, the gene encoding the pore-forming Kir6.2 subunit of K ATP channels, precipitates generalized seizure, 7 heart failure 8 and arrhythmia under stress. 9 Therefore, we tested here whether K ATP channel function provides a protective mechanism in the setting of cocaine toxicity. In response to systemic administration of a toxic dose of cocaine, Kir6.2-knockout (Kir6.2-KO) mice [7] [8] [9] demonstrated a marked survival disadvantage compared to sex-and age-matched wild-type (WT) controls (Figure 1a) . Specifically, at 24-h follow-up, a single injection of cocaine (100 mg kg À1 i.p.) produced a 67% mortality in the Kir6.2-KO (n = 15) compared to 15% mortality in the WT (n = 14, P < 0.01; Figure 1a ). In fact, the absence of functional K ATP channels in the Kir6.2-deficient cohort predisposed to a prompt and massive lethality, with this propensity to aggravated mortality over WT also observed in the Kir6.2-KO following repeated cocaine abuse (P = 0.008, WT vs Kir6.2-KO; Figure 1b) . Thus, the presence of intact K ATP channels critically defines survivorship in cocaine overdose.
Despite protection afforded by K ATP channels, WT mice demonstrated a significant vulnerability to cocaine (Figures 1a and b) . Promotion of K ATP channel activity in the WT through pretreatment with À1 i.p.; P < 0.01). Conversely, pretreatment with the K ATP channel opener pinacidil (pin, 15 mg kg À1 , i.p.) abrogated mortality in WT (P < 0.05). Cohort size provided in parentheses. (b) Aggravated mortality trends following repeated cocaine abuse (100 mg kg À1 , i.p. once daily) in Kir6.2-KO vs WT (P = 0.008). Pretreatment with pinacidil (15 mg kg À1 , i.p., 30 min before each cocaine injection) abrogated cumulative mortality with improved long-term survival (P < 0.01) over WT (without pinacidil). Statistical analysis was performed using Pearson's w 2 or log-rank tests as appropriate.
